← Back to Clinical Trials
Recruiting NCT05896475

NCT05896475 Risk Factors for Asymptomatic Rotator Cuff Tears to Become Symptomatic.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05896475
Status Recruiting
Phase
Sponsor University Ghent
Condition Rotator Cuff Tears
Study Type OBSERVATIONAL
Enrollment 207 participants
Start Date 2023-06-02
Primary Completion 2025-06

Trial Parameters

Condition Rotator Cuff Tears
Sponsor University Ghent
Study Type OBSERVATIONAL
Phase N/A
Enrollment 207
Sex ALL
Min Age 55 Years
Max Age 100 Years
Start Date 2023-06-02
Completion 2025-06

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

In this prospective study, subjects older than 55 years with a degenerative asymptomatic rotator cuff tears will be followed for a period of 2 years. After testing, a symptom registration form will be filled in every 3 months. The test moment consists of pain measurements (pain pressure thresholds and conditioned pain modulation), biomechanical measurements (strength (including hand grip strength), range of motion, ultrasound (while measuring electromyographic activity) and shear wave elastography) and psychosocial measurements (psychosocial questionnaires).

Eligibility Criteria

Inclusion Criteria: * 55+ years old * male or female * asymptomatic rotator cuff tear diagnosed with ultrasound by a medical doctor * mean visual analogue score (VAS) of \< 3 during daily life activities * no shoulder complaints having a significant influence on daily life activities Exclusion Criteria: * recent shoulder trauma * massive rotator cuff tears * small partial thickness tears * neck complaints * history of shoulder surgery * history of proximal upper arm fracture * frozen shoulder * inflammatory arthritis * peripheral or central disorders * cognitive disorders

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology